Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II

NCT01706406 | Completed

• 1 other identifier: C05-0400-II
• Study Type: interventional
• Target: 98
• Locations: 1 country
• Sites: 2

Brief Summary

The purpose of this study is to pilot test and determine the efficacy of a psychoeducational intervention (PED) we recently piloted in a group format for women with acquired sexual arousal disorder (FSAD). HYPOTHESES:

1. 1.\- Compared to baseline measures, the PED will result in significant improvement in self-report measures of: (a) subjective sexual arousal; (b) perception of genital arousal/genital sensitivity; (c) orgasmic experience; (d) sexual desire; (e) sexual distress; (f) relationship satisfaction; (g) depressive symptoms; and (h) quality of life.
2. 2.\- It is unknown what effect the PED will have on actual physiological sexual arousal.
3. 3.\- The group format will be a feasible and cost-effective method of delivering empirically supported treatment to women with sexual arousal difficulties and will contribute towards meeting the needs for sexual health care for women on the clinic wait-list at the BC Centre for Sexual Medicine.

Conditions

Low Female Sexual Arousal; Low Female Sexual Desire

Keywords

female sexual arousal; female sexual desire; psychoeducational intervention

Outcome Measures

Primary Outcomes (2)

• Change in physiological sexual arousal

  Sexual arousal will be measured physiologically with a Vaginal Photoplethysmograph (VPP). The VPP measures vaginal pulse amplitude (VPA) which has been found to be a sensitive and specific measure of genital arousal (Laan \& Everaerd, 1995).

  Sexual arousal will be measured approximately one week pre-treatment and approxiately two weeks post-treatment

• Long-term change in physiological sexual arousal

  Sexual arousal will be measured physiologically with a Vaginal Photoplethysmograph (VPP). The VPP measures vaginal pulse amplitude (VPA) which has been found to be a sensitive and specific measure of genital arousal (Laan \& Everaerd, 1995).

  Sexual arousal will be assessed approximately one-week pre-treatment and approximately 6 months post treatment

Secondary Outcomes (1)

• Subjective sexual arousal

  Subjective sexual arousal will be assessed approximately one week pre-treatment, approximately two-weeks post-treatment and approximately 6-months post treatment

Other Outcomes (2)

• Sexual Distress

  Sexual distress will be assessed approximately one week pre-treatment, approximatley two weeks post-treatment and approximately 6-months post-treatment

• Mood

  Mood will be assessed approximately one week pre-treatment, approximatley two weeks post-treatment and approximately 6-months post-treatment

Study Arms (2)

1 treatment

EXPERIMENTAL

Women randomized into the "treatment" group will undergo pre-treatment testing (questionnaires and physiological assessment)within 14 days of beginning treatment

Behavioral: Brief psychoeducational intervention for female sexual arousal disorder

2 waitlist

OTHER

Women randomized to the "waitlist" group will undergo initial testing (questionnaires and physiological testing) and receive no treatment until the next scheduled group (4 months). They will undergo pretreatment testing and treatment on the same schedule as women in the "treatment" group.

Behavioral: Brief psychoeducational intervention for female sexual arousal disorder

Interventions

Brief psychoeducational intervention for female sexual arousal disorder BEHAVIORAL

four 1.5 hour long group psychoeducational sessions, spaced 2 weeks apart for a total of 8 weeks.

1 treatment; 2 waitlist

Eligibility Criteria

• Age: 19 Years - 65 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• between the ages of 19 and 65
• currently seeking treatment at the BC Centre for Sexual Medicine
• meet clinical criteria for acquired Female Sexual Arousal Disorder (FSAD);
• be proficient in English and willing to take part in group sessions.

You may not qualify if:

• does not meet clinical criteria for acquired Female Sexual Arousal Disorder (FSAD)
• not currently Seeking seeking treatment at the BC Centre for Sexual Medicine

Sponsors & Collaborators

• University of British Columbia: lead

Study Sites (2)

BC Centre for Sexual Medicine

Vancouver, British Columbia, V5Z 1C6, Canada

Location

UBC Sexual Health Lab, Vancouver Hospital

Vancouver, British Columbia, V5Z 1M9, Canada

Location

Related Links

• UBC Sexual Health Lab website

Study Officials

• Lori A Brotto, PhD

  University of British Columbia

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: October 29, 2010
• First Posted: October 15, 2012
• Study Start: November 1, 2007
• Primary Completion: June 1, 2012
• Study Completion: June 1, 2012
• Last Updated: June 1, 2017

Record last verified: 2017-05

Locations

CA (2)